- Home
- NXTC vs TOMZ Comparison
NXTC vs TOMZ Comparison
Compare NXTC & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- TOMZ
- Stock Information
- Founded
- NXTC 2015
- TOMZ 1979
- Country
- NXTC United States
- TOMZ United States
- Employees
- NXTC N/A
- TOMZ N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- TOMZ Diversified Commercial Services
- Sector
- NXTC Health Care
- TOMZ Finance
- Exchange
- NXTC Nasdaq
- TOMZ Nasdaq
- Market Cap
- NXTC 21.6M
- TOMZ 20.2M
- IPO Year
- NXTC 2019
- TOMZ N/A
- Fundamental
- Price
- NXTC $0.72
- TOMZ $0.94
- Analyst Decision
- NXTC Strong Buy
- TOMZ Strong Buy
- Analyst Count
- NXTC 2
- TOMZ 1
- Target Price
- NXTC $4.00
- TOMZ $3.50
- AVG Volume (30 Days)
- NXTC 61.8K
- TOMZ 30.2K
- Earning Date
- NXTC 03-20-2025
- TOMZ 03-31-2025
- Dividend Yield
- NXTC N/A
- TOMZ N/A
- EPS Growth
- NXTC N/A
- TOMZ N/A
- EPS
- NXTC N/A
- TOMZ N/A
- Revenue
- NXTC N/A
- TOMZ $8,197,404.00
- Revenue This Year
- NXTC N/A
- TOMZ $40.32
- Revenue Next Year
- NXTC N/A
- TOMZ $38.17
- P/E Ratio
- NXTC N/A
- TOMZ N/A
- Revenue Growth
- NXTC N/A
- TOMZ N/A
- 52 Week Low
- NXTC $0.66
- TOMZ $0.52
- 52 Week High
- NXTC $2.57
- TOMZ $1.50
- Technical
- Relative Strength Index (RSI)
- NXTC 40.34
- TOMZ 45.57
- Support Level
- NXTC $0.66
- TOMZ $0.89
- Resistance Level
- NXTC $0.79
- TOMZ $1.08
- Average True Range (ATR)
- NXTC 0.06
- TOMZ 0.06
- MACD
- NXTC 0.00
- TOMZ -0.01
- Stochastic Oscillator
- NXTC 42.21
- TOMZ 26.32
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease.
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a bacteria decontamination and infectious disease control company, providing environmental solutions for indoor surface decontamination through the manufacturing, sales, service and licensing of its SteraMist brand of products, including SteraMist BIT, a low percentage (7.8%) hydrogen peroxide-based fog or mist that uses Binary Ionization Technology (BIT). Its product portfolio includes SteraMist Surface Unit; SteraMist Environment System; The SteraMist Total Disinfection Cart; SteraMist Select Surface Unit; Stainless Steel 90 Degree Applicator; iHP Plasma Decontamination Chamber; SteraMist Custom Engineered System (CES); and iHP Corporate Service Decontamination.